Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects

Interstitial lung disease (ILD), as an adverse effect of certain drugs, leads to inflammation and damage in the walls of the alveoli, making it difficult for the alveoli to take up oxygen. Interstitial pneumonia with no identifiable cause is called idiopathic interstitial pneumonia (IIP), and, among...

Descripción completa

Detalles Bibliográficos
Autores principales: Nawa, Hideki, Hamano, Hirofumi, Niimura, Takahiro, Miyata, Koji, Yagi, Kenta, Goda, Mitsuhiro, Zamami, Yoshito, Ishizawa, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747116/
https://www.ncbi.nlm.nih.gov/pubmed/36128688
http://dx.doi.org/10.1111/cts.13419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747116/
https://www.ncbi.nlm.nih.gov/pubmed/36128688
http://dx.doi.org/10.1111/cts.13419

Ejemplares similares